Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AATD, accrual, alongside, apportioned, backsolve, BEACON, beneficiary, brochure, clearance, complaint, CR, cumulative, cytokine, decided, decline, entry, exceeded, exit, fifteen, formal, group, iii, independent, influence, investee, iv, JSC, magnitude, memo, modulate, mutual, NOL, nonclinical, noncontrolling, Orbital, outlook, permit, presence, pretax, qualitative, quantitative, rearrangement, regenerative, rejected, representation, residual, resolution, ribonucleic, specialist, subordinated, temporary, tracked, unspecified, usage, vi
Removed:
cytosine, forecast, state, toxicology
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view